Research programme: colloidal gadolinium oxide diagnostics - BioPhysics Assay Laboratory
Latest Information Update: 16 Jul 2016
At a glance
- Originator BioPhysics Assay laboratory
- Developer BioPhysics Assay Laboratory
- Class Gadolinium-containing contrast agents
- Mechanism of Action Magnetic resonance imaging enhancers
Orphan Drug Status
Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.
On Fast track
Fast track status is assigned by the US FDA so therapies with the potential to address unmet needs can move faster through development.
Highest Development Phases
- No development reported Cardiovascular disorders
Most Recent Events
- 16 Jul 2016 No recent reports of development identified for preclinical development in Cardiovascular-disorders(Diagnosis) in USA
- 28 Nov 2005 Preclinical trials in Cardiovascular disorders (diagnosis) in USA (unspecified route)